Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.

Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L.

Nat Chem Biol. 2009 Feb;5(2):100-7. doi: 10.1038/nchembio.137. Epub 2009 Jan 4.

2.

[Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].

Liu Y, Zhang CG, Zhou CY.

Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Apr 18;42(2):238-42. Review. Chinese.

3.

Wnt/beta-catenin signaling: components, mechanisms, and diseases.

MacDonald BT, Tamai K, He X.

Dev Cell. 2009 Jul;17(1):9-26. doi: 10.1016/j.devcel.2009.06.016. Review.

4.

Regulation of Wnt/beta-catenin signaling by protein kinases.

Verheyen EM, Gottardi CJ.

Dev Dyn. 2010 Jan;239(1):34-44. doi: 10.1002/dvdy.22019. Review.

5.

Wnt/beta-catenin signaling: new (and old) players and new insights.

Huang H, He X.

Curr Opin Cell Biol. 2008 Apr;20(2):119-25. doi: 10.1016/j.ceb.2008.01.009. Epub 2008 Mar 12. Review.

6.

The Wnt/β-catenin signaling pathway in liver biology and disease.

Behari J.

Expert Rev Gastroenterol Hepatol. 2010 Dec;4(6):745-56. doi: 10.1586/egh.10.74. Review.

7.

PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.

Fearon ER.

Cancer Cell. 2009 Nov 6;16(5):366-8. doi: 10.1016/j.ccr.2009.10.007. Review.

8.

Targeting the Wnt/β-catenin signaling pathway in human cancers.

Yao H, Ashihara E, Maekawa T.

Expert Opin Ther Targets. 2011 Jul;15(7):873-87. doi: 10.1517/14728222.2011.577418. Epub 2011 Apr 12. Review.

PMID:
21486121
9.

New avenues to target Wnt/β-catenin signaling.

Verkaar F, Zaman GJ.

Drug Discov Today. 2011 Jan;16(1-2):35-41. doi: 10.1016/j.drudis.2010.11.007. Epub 2010 Nov 24. Review.

PMID:
21111060
10.

Toggling a conformational switch in Wnt/β-catenin signaling: regulation of Axin phosphorylation. The phosphorylation state of Axin controls its scaffold function in two Wnt pathway protein complexes.

Tacchelly-Benites O, Wang Z, Yang E, Lee E, Ahmed Y.

Bioessays. 2013 Dec;35(12):1063-70. doi: 10.1002/bies.201300101. Epub 2013 Sep 19. Review.

11.

Axin: a master scaffold for multiple signaling pathways.

Luo W, Lin SC.

Neurosignals. 2004 May-Jun;13(3):99-113. Review.

PMID:
15067197
12.
13.
14.

The Wnt/beta-catenin signaling pathway as a target in drug discovery.

Takahashi-Yanaga F, Sasaguri T.

J Pharmacol Sci. 2007 Aug;104(4):293-302. Review.

15.

Wnt signaling in osteosarcoma.

Lin CH, Ji T, Chen CF, Hoang BH.

Adv Exp Med Biol. 2014;804:33-45. doi: 10.1007/978-3-319-04843-7_2. Review.

PMID:
24924167
16.

Wnt and calcium signaling: beta-catenin-independent pathways.

Kohn AD, Moon RT.

Cell Calcium. 2005 Sep-Oct;38(3-4):439-46. Review.

PMID:
16099039
17.

Wnt signaling as a therapeutic target for cancer.

Herbst A, Kolligs FT.

Methods Mol Biol. 2007;361:63-91. Review.

PMID:
17172707
18.

Endocytic trafficking and Wnt/β-catenin signaling.

Pellón-Cárdenas O, Schweitzer J, D'Souza-Schorey C.

Curr Drug Targets. 2011 Jul 1;12(8):1216-22. Review.

PMID:
21561414
19.

Role of Wnt canonical pathway in hematological malignancies.

Ge X, Wang X.

J Hematol Oncol. 2010 Sep 15;3:33. doi: 10.1186/1756-8722-3-33. Review.

20.

FAK and WNT signaling: the meeting of two pathways in cancer and development.

Fonar Y, Frank D.

Anticancer Agents Med Chem. 2011 Sep;11(7):600-6. Review.

PMID:
21707509

Supplemental Content

Support Center